NO983617L - Vaksine mot Varicella Zoster virusgen 63 produkt - Google Patents

Vaksine mot Varicella Zoster virusgen 63 produkt

Info

Publication number
NO983617L
NO983617L NO983617A NO983617A NO983617L NO 983617 L NO983617 L NO 983617L NO 983617 A NO983617 A NO 983617A NO 983617 A NO983617 A NO 983617A NO 983617 L NO983617 L NO 983617L
Authority
NO
Norway
Prior art keywords
product
vaccine against
zoster virus
virus gene
varicella zoster
Prior art date
Application number
NO983617A
Other languages
English (en)
Norwegian (no)
Other versions
NO983617D0 (no
Inventor
Bernard Rentier
Catherine Sadzot
Original Assignee
Smithkline Beecham Biolog
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602617.4A external-priority patent/GB9602617D0/en
Priority claimed from GBGB9626882.6A external-priority patent/GB9626882D0/en
Application filed by Smithkline Beecham Biolog, Univ Liege filed Critical Smithkline Beecham Biolog
Publication of NO983617D0 publication Critical patent/NO983617D0/no
Publication of NO983617L publication Critical patent/NO983617L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25Varicella-zoster virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO983617A 1996-02-09 1998-08-06 Vaksine mot Varicella Zoster virusgen 63 produkt NO983617L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9602617.4A GB9602617D0 (en) 1996-02-09 1996-02-09 Vaccines
GBGB9626882.6A GB9626882D0 (en) 1996-12-24 1996-12-24 Vaccines
PCT/EP1997/000520 WO1997028820A1 (en) 1996-02-09 1997-02-04 Vaccines against varicella zoster virus gene 63 product

Publications (2)

Publication Number Publication Date
NO983617D0 NO983617D0 (no) 1998-08-06
NO983617L true NO983617L (no) 1998-10-02

Family

ID=26308641

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983617A NO983617L (no) 1996-02-09 1998-08-06 Vaksine mot Varicella Zoster virusgen 63 produkt

Country Status (20)

Country Link
EP (1) EP0879060B1 (de)
JP (1) JP2002504080A (de)
KR (1) KR100365986B1 (de)
CN (1) CN1210470A (de)
AR (1) AR005750A1 (de)
AT (1) ATE390146T1 (de)
AU (1) AU723555B2 (de)
BR (1) BR9707400A (de)
CA (1) CA2245545C (de)
CZ (1) CZ289971B6 (de)
DE (1) DE69738597T2 (de)
ES (1) ES2301175T3 (de)
HU (1) HUP0001991A3 (de)
IL (1) IL125440A (de)
NO (1) NO983617L (de)
NZ (1) NZ331164A (de)
PL (1) PL188457B1 (de)
TR (1) TR199801531T2 (de)
TW (1) TW575427B (de)
WO (1) WO1997028820A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69838992T2 (de) * 1997-09-05 2008-12-24 Glaxosmithkline Biologicals S.A., Rixensart Öl-in-Wasser Emulsionen mit Saponinen
TR200002608T2 (tr) * 1998-03-09 2000-11-21 Smithkline Beecham Biologicals S.A Kombine aşı kompozisyonları
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
DE69937258T2 (de) * 1999-11-03 2008-07-03 Powderject Vaccines, Inc., Madison Genetische impfstoffe mit adjuvans
WO2001062778A2 (en) * 2000-02-23 2001-08-30 Smithkline Beecham Biologicals S.A. Tumour-specific animal proteins
NZ596501A (en) 2009-05-27 2013-11-29 Glaxosmithkline Biolog Sa Casb7439 constructs
AU2014214844B2 (en) 2013-02-07 2017-12-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
AU2022342080A1 (en) 2021-09-09 2024-03-28 Affinivax, Inc. Multivalent pneumococcal vaccines
CN117224664B (zh) * 2023-10-23 2024-05-24 简达生物医药(南京)有限公司 一种重组带状疱疹疫苗注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
ES2071770T3 (es) * 1989-06-27 1995-07-01 Smithkline Beecham Biolog Nuevos compuestos.

Also Published As

Publication number Publication date
EP0879060B1 (de) 2008-03-26
EP0879060A1 (de) 1998-11-25
ES2301175T3 (es) 2008-06-16
JP2002504080A (ja) 2002-02-05
CN1210470A (zh) 1999-03-10
DE69738597T2 (de) 2008-07-24
HUP0001991A3 (en) 2003-08-28
AR005750A1 (es) 1999-07-14
HUP0001991A2 (hu) 2000-10-28
TW575427B (en) 2004-02-11
NO983617D0 (no) 1998-08-06
CA2245545A1 (en) 1997-08-14
CA2245545C (en) 2008-12-30
IL125440A0 (en) 1999-03-12
KR19990082360A (ko) 1999-11-25
ATE390146T1 (de) 2008-04-15
PL328414A1 (en) 1999-01-18
NZ331164A (en) 2000-02-28
WO1997028820A1 (en) 1997-08-14
DE69738597D1 (de) 2008-05-08
CZ248698A3 (cs) 1998-12-16
IL125440A (en) 2002-02-10
PL188457B1 (pl) 2005-02-28
AU1601297A (en) 1997-08-28
TR199801531T2 (xx) 1998-10-21
KR100365986B1 (ko) 2003-02-20
AU723555B2 (en) 2000-08-31
CZ289971B6 (cs) 2002-05-15
BR9707400A (pt) 2000-01-04

Similar Documents

Publication Publication Date Title
FI923707A7 (fi) Oligonukleotidterapier foer modulering av effekten hos herpesvirus
DE59608685D1 (de) Stapler
ZA945414B (en) DNA virus ribozymes
FI954329A0 (fi) Farmaseuttisina aineina käytettäviä nukleiinihappoja
ATE209045T1 (de) Hepatitis b impfstoff
FI934295L (fi) Boggi foer jaernvaegsfordon med variabel spalt mellan hjul
FI953079L (fi) DNA:n vahvistaminen
DE69405605D1 (de) Motorisch angetriebenes Klammergerät
DE69426294D1 (de) Rehydrierbares produkt
NO983617L (no) Vaksine mot Varicella Zoster virusgen 63 produkt
DE69606124D1 (de) Abfallblasgerät
AU3900893A (en) Quantitative viral assay
IS4629A (is) Samskeyttar veirukjarnsýrur
FR11C0050I2 (fr) Virus myxomateux recombinant
ATE240392T1 (de) Spezifische oligonukleotide fuer hepatitis c- virus
ITMI932517A0 (it) Cassa di soffiante
FI973448A0 (fi) Liukulevy
ES1027324Y (es) Soplador
AU7336296A (en) Human hepatitis b virus dna
KR950702244A (ko) 백신으로서의 즉석 초기 hsv-2 비루스 단백질 icp27(immediatie early hsv-2 viral protein icp27 as vaccine)
HK1016474A (en) Vaccines against varicella zoster virus gene 63 product
KR970021240U (ko) 진공발포기
DE69402721D1 (de) Markraumnagelsystem
NO933907D0 (no) Syklonsystem
GB9517348D0 (en) Nucleic acids amplification assay